Established in 1987 as the Aids Clinical Trials Unit (ACTU), the Washington University ACTU has been a highly productive participant in the AIDS Clinical Trials Group and is funded by the National Institute of Allergy and Infectious Diseases. Centrally located in the Midwest, it draws participants from Missouri, Illinois, Arkansas, Kansas, Tennessee, Nebraska and Oklahoma. Within the Division of Infectious Diseases, this ACTU is considered among the finest in the world.
The Washington University Infectious Diseases Clinical Research Unit (ID-CRU), as it is now known, is highly regarded for their expertise and is well established in the community. Led by Rachel Presti, MD, PhD, the ID-CRU provides access to HIV and Infectious Disease research opportunities, community outreach and education.
Team
Luis Parra-Rodriguez, MD
Assistant Professor of Medicine
- Email: lparra-rodriguez@wustl.edu
Dr. Parra-Rodriguez specializes in the longitudinal clinical care of people with HIV, with a special clinical research focus on aging, age-related clinical conditions, and mental health in people with HIV.
Rachel M. Presti, MD, PhD
Professor, Infectious Diseases | Medical Director of the Infectious Disease Clinical Research Unit (IDCRU)
- Phone: 314-454-8215
- Fax: 314-454-5392
- Email: prestir@wustl.edu
Dr. Presti specializes in clinical and translational research in infectious disease, with a special focus on HIV, SARS-CoV-2 and other viral infections.
Adriana M. Rauseo, MD
Assistant Professor of Medicine
- Phone: 314-454-8254
- Email: a.rauseoacevedo@wustl.edu
Dr. Rauseo specializes in clinical infectious diseases, with a special focus on mycology and infectious that affect immunocompromised hosts. Since the outset of the COVID-19 pandemic she has served as an investigator in the Infectious Disease Clinical Research Unit (ID-CRU) in multiple clinical trials and translational research in the fight against COVID-19.